GENE ONLINE|News &
Opinion
Blog

Funding
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Theravance Allots $250 Million to Repurchase Shares, Removing GSK as a Shareholder
2022-09-20
Big Pharma-Backed Capstan Launches With $165 Million To Combine Cell Therapy And mRNA Technology
2022-09-15
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
2022-09-14
Series D Funding Brings Radiopharmaceutical Company RayzeBio to $418 million in Total
2022-09-13
Pretzel Therapeutics Starts Off With $72.5 Million To Modify Mitochondria
2022-09-13
Competing With BMS’s New Psoriasis Drug, Nimbus Gathers $125 Million to Advance Development
2022-09-13
RNA-Focused Orbital Therapeutics Makes its Industry Debut with Beam Partnership
2022-09-08
NC – Life Sciences Manufacturing Coalition Wins $25 million in Grant Funding
2022-09-02
NIH Provides $23 Million to Fund Telehealth Cancer Care Research
2022-08-22
Flossy Raises 14.7M to Expand Oral Care Accessibility
2022-08-19
Gilead Sciences Promises $5 million to Combat Monkeypox Public Health Emergency
2022-08-09
Sanofi Invests in Innovent to Gain Stronger Foothold in China
2022-08-05
Novo Nordisk Increased Sales by 25% in H1 2022
2022-08-03
A $230M Deal for New Leukemia Drug Awaits FDA
2022-08-03
1 2 3 10
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!